flavone acetic acid has been researched along with Neoplasms in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 13 (65.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belluti, F; Bisi, A; Gobbi, S; Rampa, A | 1 |
| Horsman, MR; Murata, R | 1 |
| Conlon, KC; Fenton, RG; Holmund, JT; Hornung, R; Janik, JE; Kopp, WC; Longo, DL; Sznol, M; Urba, WJ; Wiltrout, RH | 1 |
| Armand, JP; Chabot, GG; de Forni, M; Gouyette, A; Klink-Alak, M; Recondo, G | 1 |
| Crom, WR; Evans, RR; Groom, S; Pratt, CB; Relling, MV | 1 |
| Baguley, BC | 1 |
| Murray, C; Watts, M | 1 |
| Bishop, JF; Olver, IN; Stokes, KH; Webster, LK | 1 |
| Boldt, DH; Clark, GN; Craig, JB; Harman, G; Havlin, KA; Koeller, J; Kuhn, JG; Schwartz, R; Von Hoff, DD; Weiss, GR | 1 |
| Moore, JV; West, DC | 1 |
| Brown, TD; Burris, HA; Havlin, KA; O'Rourke, TJ; Rodriguez, GI; Wall, JG; Weiss, GR | 1 |
| Avery, L; Douglass, EC; Kellie, SJ; Meyer, WH; Pratt, CB; Relling, MV | 1 |
| Allavena, P; Crivellari, D; D'Incalci, M; Damia, G; Favaro, D; Galligioni, E; Quaia, M; Sorio, R; Spada, A; Talamini, R | 1 |
| Grever, MR; Malspeis, L; Rinehart, JJ; Triozzi, PL; Young, DC | 1 |
| Brodfuehrer, J; Chan, K; Corbett, T; Heilbrun, L; Valeriote, F | 1 |
| Braida, A; Caruso, G; D'Incalci, M; Damia, G; Freschi, A; Monfardini, S; Quaia, M; Sorio, R | 1 |
| Cassidy, J; Kaye, SB; Kerr, DJ; Setanoians, A; Zaharko, DS | 1 |
| Ames, MM; Bowie, EJ; Kovach, JS; Nichols, WL; Rubin, J; Schutt, AJ | 1 |
| Collins, JM; Curt, GA; Greene, RF; Knight, RD; Pelosi, JJ; Sulkes, A; Weiss, RB | 1 |
| Adams, L; Bradley, C; Cassidy, J; Forrest, G; Kaye, SB; Kerr, DJ; Rankin, EM; Setanoians, A; Soukop, M; Young, T | 1 |
3 review(s) available for flavone acetic acid and Neoplasms
| Article | Year |
|---|---|
Flavonoid-Inspired Vascular Disrupting Agents: Exploring Flavone-8-Acetic Acid and Derivatives in the New Century.
Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase III as Topic; Flavonoids; Humans; Neoplasms; Xanthenes; Xanthones | 2021 |
Small-molecule cytokine inducers causing tumor necrosis.
Topics: 5-Hydroxytryptophan; Animals; Antineoplastic Agents; Capillary Permeability; Cytokines; Endothelium, Vascular; Flavonoids; Humans; Interferon-alpha; Mice; Microcirculation; Necrosis; Neoplasms; NF-kappa B; Nitric Oxide; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 2001 |
New anticancer agents.
Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Biphenyl Compounds; Chrysenes; Deoxycytidine; Echinomycin; Epirubicin; Etanidazole; Flavonoids; Gemcitabine; Guanidines; Humans; Idarubicin; Menogaril; Mitoguazone; Neoplasms; Nitroimidazoles; Nogalamycin; Organoplatinum Compounds; Paclitaxel; Pentostatin; Polymers; Propylene Glycols; Ribavirin; Sulfonylurea Compounds; Trimetrexate; Vidarabine Phosphate | 1991 |
6 trial(s) available for flavone acetic acid and Neoplasms
| Article | Year |
|---|---|
A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2.
Topics: Antineoplastic Agents; Carcinoma; Drug Administration Schedule; Female; Flavonoids; Humans; Interleukin-2; Male; Melanoma; Neoplasms; Treatment Outcome | 1995 |
Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinization.
Topics: Adult; Aged; Antineoplastic Agents; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Flavonoids; Half-Life; Humans; Hypotension; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Sleep Stages; Time Factors; Vomiting | 1995 |
Saturable elimination and saturable protein binding account for flavone acetic acid pharmacokinetics.
Topics: Antineoplastic Agents; Child; Flavonoids; Humans; Kinetics; Neoplasms; Neoplasms, Experimental; Protein Binding | 1993 |
Phase I clinical and pharmacokinetic trial of flavone acetic acid.
Topics: Adult; Aged; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Agents; CD56 Antigen; Drug Evaluation; Female; Flavonoids; Humans; Male; Middle Aged; Neoplasms; Receptors, Fc; Receptors, IgG | 1991 |
Phase I study of flavone acetic acid (NSC 347512, LM975) in patients with pediatric malignant solid tumors.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Drug Evaluation; Female; Flavonoids; Humans; Least-Squares Analysis; Male; Neoplasms | 1991 |
Natural killer (NK) and lymphokine activated killer (LAK) cell activity in patients (PTS) treated with flavone acetic acid (FAA).
Topics: Adjuvants, Immunologic; Adult; Aged; Cells, Cultured; Drug Evaluation; Female; Flavonoids; Humans; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukocytes, Mononuclear; Male; Middle Aged; Neoplasms; Reference Values | 1991 |
11 other study(ies) available for flavone acetic acid and Neoplasms
| Article | Year |
|---|---|
Combination of vascular targeting agents with thermal or radiation therapy.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Radiation; Flavonoids; Hyperthermia, Induced; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Stilbenes; Temperature; Time Factors; Tumor Cells, Cultured; X-Rays; Xanthenes; Xanthones | 2002 |
Endothelial cells in tumours: the challenge.
Topics: Animals; Cell Survival; Endothelium, Vascular; Flavonoids; Humans; Immunotoxins; Neoplasms | 1992 |
A phase I and pharmacokinetic study of 12-h infusion of flavone acetic acid.
Topics: Adult; Antineoplastic Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Evaluation; Flavonoids; Humans; Infusions, Intravenous; Neoplasms; Remission Induction; Time Factors | 1992 |
Vasculature as a target for anti-cancer therapy.
Topics: Animals; Antibodies, Monoclonal; Blood Coagulation; Endothelium, Vascular; Flavonoids; Humans; Hyperthermia, Induced; Immunologic Factors; Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Photochemotherapy; Regional Blood Flow | 1991 |
Immunological effects of flavone acetic acid.
Topics: Adult; Aged; Antineoplastic Agents; Cytotoxicity, Immunologic; Female; Flavonoids; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Male; Middle Aged; Neoplasms; T-Lymphocytes | 1990 |
Flavone acetic acid and plasma protein binding.
Topics: Animals; Binding Sites; Binding, Competitive; Blood Proteins; Clofibric Acid; Flavonoids; Humans; In Vitro Techniques; Mice; Neoplasms; Protein Binding; Salicylates; Salicylic Acid; Serum Albumin | 1990 |
Flavone acetic acid distribution in human malignant tumors.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Drug Evaluation; Female; Flavonoids; Humans; Male; Mice; Middle Aged; Neoplasms; Neoplasms, Experimental; Species Specificity; Tissue Distribution | 1990 |
Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients?
Topics: Animals; Antineoplastic Agents; Blood Proteins; Chromatography, High Pressure Liquid; Flavonoids; Humans; Kinetics; Mathematics; Mice; Models, Theoretical; Neoplasms; Prognosis; Protein Binding; Species Specificity | 1989 |
Flavone-8-acetic acid inhibits ristocetin-induced platelet agglutination and prolongs bleeding time.
Topics: Antineoplastic Agents; Bleeding Time; Flavonoids; Humans; Neoplasms; Platelet Aggregation; Ristocetin | 1987 |
Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512).
Topics: Adult; Aged; Blood Pressure; Drug Evaluation; Female; Flavonoids; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms | 1988 |
Phase I and pharmacokinetic study of flavone acetic acid.
Topics: Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Flavonoids; Humans; Kinetics; Male; Middle Aged; Neoplasm Metastasis; Neoplasms | 1987 |